Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

CPC review of 5,000 sales finds Compass at 29.7% to 39.5% share in five metros, raising double-ending and private listing concerns.

Compass Pathways may be the first to benefit from an accelerated approval process.

Investing.com - Stifel reiterated a Buy rating and $12.00 price target on Compass Therapeutics (NASDAQ:CMPX) shares, well above the current stock price of $5.10. The biotech company has delivered a ...

Compass' new home listing strategy is reshaping who sees which homes, when, and at what price.

Magnetic rocks with iron oxide concentrations act as natural chroniclers of Earth's past continental movements. Using small ...

A proposed massive data center is already receiving pushback from neighbors in Iredell County. According to the Charlotte Observer, Texas-based Compass Data Centers wants to rezone 340 acres of Stamey ...

Feel the thrill of the hunt and keep an eye out for the wild and wonderous species that are roaming the Canadian wilderness.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min San Francisco's housing market ...

San Francisco home prices hit new heights in March, fueled by the vast wealth being generated by the AI industry, according to a report Monday from Compass. House prices in the city hit a record ...

The Chicago MLS, which runs a private listing network, is expanding nationwide to give agents “more choices.” It will receive ...

Midwest Real Estate Data is expanding its MLS nationwide, giving any licensed real estate agent access to its platform and PLN.